Company Name:
Company Name:



BCP Partnering Portal / Cytiva Inc

More Information on 'Cytiva Inc'

Cytiva Inc - Manufacturer based in United States of America
Other Offices: United Kingdom, China, Canada, India, None, United States of America, Denmark, Australia, Germany, Sweden, Switzerland

Announcements
https://www.cytivalifesciences.com/en/us/news-center/introducing-cytiva-global-life-sciences-leader-10001 APRIL 01, 2020 Introducing Cytiva – Global Life Sciences Leader * New Danaher operating company created following completion of $21.4B acquisition by Danaher Corporation * Previously GE Healthcare Life Sciences, Cytiva will help accelerate growth and innovation in biological therapies * Leading life sciences brands such as ÄKTA, Amersham, HyClone, MabSelect and Whatman are part of Cytiva Cytiva, a global provider of technologies and services that help advance and accelerate the development and manufacture of therapeutics, launches today. Previously GE Healthcare Life Sciences, Cytiva has nearly 7,000 employees and operations in 40 countries and is part of the Danaher Corporation Life Sciences platform. Emmanuel Ligner, President of Cytiva, says: “Our foundation of scientific expertise, our team, and our solid customer base place Cytiva in the right position to invest, develop, and accelerate growth in the industry. Our passion for helping bring life-changing therapies to patients is unwavering, and we will continue to introduce innovative technologies to the market which improve productivity for our customers.” Cytiva experts and technologies enabled breakthroughs in science and medicine that have shaped today's biotechnology industry. In 2019, more than 75 percent of the biological therapies approved by the United States Food and Drug Administration relied on Cytiva’s technologies for manufacturing. Additionally, Cytiva technology has contributed in the nascent area of cell and gene therapies and has done so since the first successful pediatric trial of CAR-T therapy in 2012. This area continues to have great potential and currently, there are more than 1,000 regenerative medicine clinical trials underway globally1. Accelerating growth, productivity, and innovation in the sector are major strategic focus areas for the company, as global demand for personalized and advanced biological therapies is ever-increasing. Cytiva drives customer-centered innovation, from idea to commercial development stages, with facilities across Asia, Europe, and the Americas. It also has centers for customer collaboration and training to enable the development of new therapies, such as the Testa Center in Uppsala, Sweden and with the University of Technology at Sydney. Cytiva will also continue to pursue collaborations for research, such as the center for advanced biological innovation and manufacturing in Boston with Harvard, MIT, teaching hospitals, and industry partners Fujifilm Diosynth Biotechnologies, and Alexandria Real Estate Equities, Inc. Cytiva’s diverse portfolio includes well-recognized brands such as ÄKTA, Amersham, Biacore, FlexFactory, HyClone, MabSelect, Sefia, Whatman, Xcellerex and Xuri. The portfolio spans a full range of instruments, consumables, digital and enterprise solutions and services for research, process development, and complete manufacturing workflows that scale according to customers’ needs. 1The Alliance for Regenerative Medicine Q3 2019 Quarterly Report ### About Cytiva Cytiva is a 3.3 billion USD global life sciences leader with nearly 7000 associates operating in 40 countries dedicated to advancing and accelerating therapeutics. As a trusted partner to customers that range in scale and scope, Cytiva brings speed, efficiency and capacity to research and manufacturing workflows, enabling the development, manufacture and delivery of transformative medicines to patients. Visit www.cytiva.com for more.

About Cytiva Inc
Cytiva is a global provider of technologies and services that advance and accelerate the development, manufacture and delivery of therapeutics. Formerly part of GE Healthcare Life Sciences, we have a rich heritage tracing back hundreds of years, and a fresh start in 2020 as a standalone operating company in the Danaher Corporation. Our customers undertake life-saving activities ranging from fundamental biological research to developing innovative vaccines, biologic drugs, and novel cell and gene therapies. Our job is to supply the tools and services they need to work better, faster and safer, leading to better patient outcomes. Cytiva is a 3.3 billion USD global life sciences leader with over 7000 associates across 40 sites who are dedicated to our vision to improve access to life-changing therapies that transform human health. As a trusted partner to customers that range in scale and scope, Cytiva brings efficiencies to research and manufacturing workflows, ensuring the development, manufacture and delivery of transformative medicines to patients.

Product Types:

Laboratory Consumables / Labware

Industries:

Life Sciences
Pharma & Biotech

Products, Services & Applications:

Molecular Biology
Proteomics
Single Cell Analysis
Therapeutics
Verified Member
The BCP Partnering Portal

Where Manufacturers and Channel Partners / Distributors find each other!

  • The BCP Partnering Portal is a specialized matchmaking platform featuring over 27,000 company profiles, who supply products and services within scientific fields. It serves as a crucial resource for facilitating B2B partnerships between manufacturers and channel partners.
  • Developed by BioChannel Partners Ltd, an award-winning B2B partnering company with over 22 years of expertise in connecting manufacturers and channel partners of scientific products, the portal ensures that company profiles are kept up-to-date by both the BCP team and verified profile owners.
  • This continuous update process ensures that users have access to accurate and current information, enhancing the platform's effectiveness in fostering successful business collaborations.
  • Take advantage of this resource and join to manage your own company profile and search for new partners.


Location:

39 Sussex Road, Bury St Edmunds, Suffolk, IP32 6TE, United Kingdom

Phone: +44 (0) 1284 756 440

Email: info@biochannelpartners.com

©2025, BioChannel Partners, Terms and Conditions,  Privacy Policy

>